Skip to main content
Karolinska Development logo

Karolinska Development — Investor Relations & Filings

Ticker · KDEV ISIN · SE0002190926 LEI · 54930011ZA52NKO5W681 ST Financial and insurance activities
Open in API
Filings indexed 761 across all filing types
Latest filing 2024-03-22 Annual Report (ESEF)
Country SE Sweden
Listing ST KDEV

About Karolinska Development

https://www.karolinskadevelopment.com/en

Karolinska Development is an investment company specializing in the life sciences sector. It identifies, finances, and supports the creation and growth of companies developing innovative medical technologies and pharmaceuticals. The firm manages a diversified portfolio of biotechnology and medtech ventures, often originating from academic research, with the goal of developing ground-breaking treatments for severe diseases. Karolinska Development leverages its team's expertise in research, development, and commercialization to guide its portfolio companies, providing both capital and strategic support to advance innovations toward the market.

Recent filings

Filing Released Lang Actions
Annual Report (ESEF) 2023
Annual Report (ESEF) Classification · 1% confidence FY 2023
2024-03-22 Swedish
Annual Report (ESEF) 2023
Annual Report (ESEF) Classification · 1% confidence FY 2023
2024-03-22 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 1% confidence The document is titled 'BOKSLUTSKOMMUNIKÉ Jan-Dec 2023' (Year-End Report) for Karolinska Development. It contains comprehensive financial data for the fourth quarter and the full fiscal year, including income statements, balance sheet items (portfolio value, cash position), and detailed management commentary on business trends and portfolio company performance. It is a substantive financial report for a period shorter than a full fiscal year (in the context of the Q4/Year-End reporting cycle) and contains actual financial statements and analysis, fitting the definition of an Interim/Quarterly Report. Q4 2023
2024-02-16 Swedish
Earnings Release 2023
Earnings Release Classification · 1% confidence The document provides a detailed financial update covering the 'Fourth quarter' and 'Full year' results for Karolinska Development, including net profit/loss, fair value changes, net asset value, investments, and cash positions as of December 31, 2023. It also includes a CEO commentary and a 'Chief Executive's Report' discussing portfolio company progress. This structure—comprehensive financial review for a full fiscal year, including quarterly highlights—is characteristic of an Annual Report (10-K) or a very detailed Interim/Quarterly Report (IR). Since it covers the full year (2023) and contains extensive management discussion and analysis (MD&A) alongside the financial figures, it strongly aligns with the content expected in a comprehensive annual filing. Although it is not explicitly labeled '10-K', the depth and scope covering the entire fiscal year make it the most appropriate classification among the options, fitting the definition of a comprehensive annual performance review, even if it might be an unlisted annual report or a very detailed year-end IR. Q4 2023
2024-02-16 English
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 1% confidence The document is titled 'DELÅRSRAPPORT Jan-Sep 2023' (Interim Report Jan-Sep 2023) for Karolinska Development. It contains comprehensive financial data, including income statements, balance sheet metrics, portfolio valuations, and detailed management commentary on business trends and outlook for the specified period. It is a substantive financial report rather than a mere announcement or certification. 9M 2023
2023-11-17 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report for the third quarter of 2023, titled 'Financial Update' and 'Chief Executive's Report'. It contains detailed financial data, including net profit/loss, earnings per share, net asset value, and cash flow analysis for the period January-September 2023. It also provides a detailed review of portfolio company performance and significant events. As it covers a period shorter than a full fiscal year and includes substantive financial statements and management analysis, it is classified as an Interim/Quarterly Report. Q3 2023
2023-11-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.